Serous Cystadenocarcinoma
2 clinical trials · Condition
◉ Watch Serous Cystadenocarcinoma
| Record | Firm | Date |
|---|---|---|
| Nivolumab and Ipilimumab in Treating Patients With Rare Tumors (NCT02834013) | National Cancer Institute (NCI) | 2017-01-30 |
| Biomarkers for Early Detection of Ovarian Cancer Using Uterine Lavage (NCT03150121) | Sheba Medical Center | 2014-06-29 |
Track Serous Cystadenocarcinoma automatically
Every clearance here is in the API, with alerts when new ones post.